CNRS Technologies

Find the best CNRS technologies to boost your innovative project.

Newest patents

You are a research scientist?

We can guide you through the whole technology transfer process.

See all our services

You are a corporate player?

Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.

Contact us

Follow our news and upcoming events

Discover CNRS technologies

Meet our team

Close

Method and device for measuring in real time the dose distribution during ion beam therapy by means of prompt gamma detection

Reference

02109-01

Patents status

French patent application FR0853038 filed on May 7th,2008 entitled: “Monitorage en temps réel du profil de la dose lors d’un traitement par hadronthérapie par détection des gamma prompts résolue en énergie, spatialement et temporellement”

Inventors

Etienne TESTA
Cédric RAY
Nicolas FREUD

commercial status

Research agreement, exclusive or non exclusive licenses

Laboratory

Institut de Physique Nucléaire de Lyon, (UMR5822), Villeurbanne, France, http://lyoinfo.in2p3.fr/

Description

The invention relates to a process and a device to measure the real time dose distribution during the irradiation of a patient by light ion beams.

TECHNICAL DESCRIPTION

The principle of the device is based on the detection of prompt gamma-rays emitted during nuclear interactions of the incident ions within the target. The gamma detection allows to determine the spatial distribution of nuclear interactions, which is strongly correlated to the dose distribution. The time of flight technique is used to discriminate the prompt-gamma signals from the background mainly due to neutrons (neutrons are detected a few nanoseconds after the arrival of prompt gammas). To locate the 3D position of the gamma point of emission, a beam hodoscope is used to determine the trajectory of every incident ion. Depending on the kind of gamma detection system chosen, the nuclear reaction point corresponds to the intersection of the ion trajectory given by the hodoscope with i) the gamma detection plane in the case of a 1D gamma-camera, ii) a cone in the case of a Compton Camera. The type of gamma-camera will be chosen on the basis of efficiency, signal-to-noise ratio and spatial resolution considerations.

Diagram of the real-time dose monitoring device
where the gamma detection system is a 1D gamma-camer
 

BENEFITS

The only method currently available for dose monitoring in situ during ion beam therapy is Positron Emission Tomography (PET) which provides a 3D-control of the dose after the treatment.

The two main advantages of our system based on prompt-gamma detection are the following:

– Real-time control of the longitudinal dose (as a function of the penetration depth in the patient) and possibly of the 2D or 3D dose distribution.

– Absence of blurring effect as observed with PET (due to the metabolic wash-out of the radioactive nuclei).

INDUSTRIAL APPLICATIONS

Prompt-gamma imaging is a new method for ensuring that the treatment is actually delivered as prescribed by the radiotherapist, making it possible to take full advantage of the ballistic precision of proton or light ion beams (hadrontherapy).

For further information, please contact us (Ref 02109-01)


Need further information ?

Contact us
Close

Contact us

  • This field is for validation purposes and should be left unchanged.
Close

Newest patents